Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Herpes Simplex
Interventions
DRUG

Famciclovir

Famciclovir sprinkle capsules, 25 mg and 100 mg, using OraSweet® syrup vehicle

Trial Locations (13)

10032

Columbia University Medical Center, New York

27710

Duke University Medical Center, Durham

44106

University Hospitals of Cleveland, Cleveland

60614

Children's Memorial Hospital, Chicago

75235

Children's Medical Center of Dallas, Dallas

77030

Baylor College of Medicine/Texas Children's Hospital, Houston

80218

The Children's Hospital, Denver

35233-1711

University of Alabama at Birmingham, Birmingham

40202-3830

Kosair Charities Pediatric Clinical Research Unit, Louisville

11794-3362

State University of New York at, Stony Brook

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

Unknown

Panama Minister of Health, David

Panama Minister of Health, Panama City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY